Everest Medicines Ltd
HKEX:1952
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Everest Medicines Ltd
HKEX:1952
|
CN |
|
UAngel Corp
KRX:072130
|
KR |
|
Cyberstep Inc
TSE:3810
|
JP |
|
S
|
SSH Communications Security Oyj
OMXH:SSH1V
|
FI |
|
V
|
Vimi Fasteners SpA
MIL:VIM
|
IT |
|
B
|
Banco Santander-Chile
SGO:BSANTANDER
|
CL |
|
ULS Technology PLC
LSE:ULS
|
UK |
|
Wipro Ltd
NSE:WIPRO
|
IN |
|
O
|
Okayamaken Freight Transportation Co Ltd
TSE:9063
|
JP |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
Federal Corp
TWSE:2102
|
TW |
Wall Street
Price Targets
Price Targets Summary
Everest Medicines Ltd
According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 65.44 HKD with a low forecast of 46.26 HKD and a high forecast of 92.4 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Everest Medicines Ltd's stock price target?
Price Target
65.44
HKD
According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 65.44 HKD with a low forecast of 46.26 HKD and a high forecast of 92.4 HKD.
What is Everest Medicines Ltd's Revenue forecast?
Projected CAGR
54%
The compound annual growth rate of Everest Medicines Ltd's revenue for the next 4 years is 54%.
